Category Archives: HIV

11.14.19

The Challenges of Turning Policies Into Data

By | Leave a Comment

If you’re reading this blog, you’re probably more than familiar with evidence-based policymaking. You may not be as used to thinking about laws and policies themselves as a form of data. But they can be. By collecting, mapping and analyzing laws/policies across jurisdictions and over time, we can systematically evaluate the relationships between policies and […]

Posted in Global Health, Global Health Governance, HIV ;

11.08.19

Overdose Prevention Sites Are an Effective Approach to Address Infectious Diseases Associated with Injection Drug Use

By | Leave a Comment

The United States has been battling a serious drug use epidemic for several years. While opioids including prescription opioids and illegal opioids like heroin and illicitly manufactured fentanyl have received significant attention, other drug use, including use of stimulants like cocaine and methamphetamine, remain major public health issues as well. Drug overdose deaths continue to increase, and […]

Posted in HIV, Infectious Diseases ;

10.18.19

More or the same? Reflecting on debates around the Global Fund’s mandate

By | Leave a Comment

Last week, the Global Fund met its replenishment target of $14B. The news was greeted mostly with sighs of relief, especially because it was a near thing. The Global Fund is the largest star in the global health firmament, channeling more money than any other multilateral actor.* It has leveraged this funding to impressive ends. […]

Posted in Global Health, Global Health Governance, HIV, TB ;

09.27.19

HIV Policy Plans Must Have a Focus on Gay and Bisexual Men

By | Leave a Comment

Today is National Gay Men’s HIV/AIDS Awareness Day. Gay, bisexual, and other men who have sex with men (MSM) are the population most affected by HIV in the United States. While gay and bisexual men make up about 2% of the population, they accounted for 70% of the 38,379 new HIV diagnoses in the United […]

Posted in HIV, Infectious Diseases ; Tagged: , , .

09.27.19

Migrants’ Access to Healthcare: Data Wanted

By | Leave a Comment

Countries’ obligations to respond to the health needs of migrants (including regular and irregular migrants, refugees, and asylum-seekers) was a topic of conversation at the O’Neill Institute this week. In 2016, the UN General Assembly adopted the New York Declaration for Refugees and Migrants, which proclaims Member States’ “commit[ment] to protecting the safety, dignity and […]

Posted in Global Health, Global Health Governance, HIV, Legal Issues ;

08.30.19

Rethinking the Deferral Period on Blood Donation: A More Tailored Measure than General Deferral on Men Who Have Sex with Men

By | Leave a Comment

The French government recently lifted its blood donation ban on men who have sex with men (MSM). Currently, gay and bisexual men must abstain from having sex with men for 12 months in order to donate blood. As of February 1, 2020, the deferral period will be 4 months instead of 12. Ultimately, the French […]

Posted in HIV ;

08.26.19

O’Neill Institute Releases Publication on Scaling Up PrEP Use for HIV Prevention

By | Leave a Comment

Last week, the National HIV/AIDS Initiative at the O’Neill Institute for National and Global Health Law released three new publications. I previously discussed two of these publications in a blog post. This week, I will discuss the remaining publication, Big Ideas: Achieving Sufficient Scale of PrEP Use Is Critical to Ending the HIV Epidemic. This […]

Posted in HIV ; Tagged: , .

08.22.19

O’Neill Institute Releases Publications on HIV Cluster Detection

By | Leave a Comment

Today, the National HIV/AIDS Initiative at the O’Neill Institute released three new publications. The publications are intended as resources to support the effort to end the HIV epidemic in the United States. President Trump announced his Administration’s Ending the HIV Epidemic (EHE) Initiative in this year’s State of the Union address, with the goal of […]

Posted in HIV ; Tagged: , .

07.19.19

Improving Laws to Support PrEP Access and HIV Prevention for Young People

By | Leave a Comment

Pre-exposure prophylaxis (PrEP) is a highly effective method of HIV prevention. Data from the Centers for Disease Control and Prevention show that PrEP use among gay, bisexual, and other men who have sex with men (MSM) increased 500% from 2014 to 2017, although uptake among other groups remains lower and disparities among MSM continue to […]

Posted in HIV ; Tagged: , .

06.12.19

USPSTF Recommendation for PrEP: Reflections on Insurance Coverage and HIV Prevention for Older Adults

By | Leave a Comment

Yesterday the U.S. Preventive Services Task Force, a federally-appointed independent panel of clinicians and scientists that conducts evidence-based reviews of preventive services, issued a final “Grade A” recommendation for pre-exposure prophylaxis (PrEP). An “A” letter grade indicates that the panel recommends the service and finds there is high certainty that the service has a substantial […]

Posted in Healthcare, HIV ;

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.